Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers

Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers

  • CN 101,460,630 A
  • Filed: 01/04/2007
  • Published: 06/17/2009
  • Est. Priority Date: 01/04/2006
  • Status: Active Application
First Claim
Patent Images

1. whether assess patient suffers from the method for ovarian cancer, this method is included at least two kinds of markers of assessment from the sample that the patient obtains, comprise HE4 marker and the another kind of marker that is selected from SMRP, CA125 and CA72-4, wherein the rising of the level of marker increases relevant with the possibility that the patient suffers from ovarian cancer.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×